[Viral clearance in wild-type hepatitis B virus after treatment with pegylated interferon alpha-2a]

Gastroenterol Hepatol. 2008 Nov;31(9):625-6. doi: 10.1157/13128310.
[Article in Spanish]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antiviral Agents / therapeutic use*
  • Hepatitis B Antibodies / blood
  • Hepatitis B Antigens / blood
  • Hepatitis B virus / isolation & purification*
  • Hepatitis B, Chronic / complications
  • Hepatitis B, Chronic / drug therapy*
  • Hepatitis B, Chronic / virology
  • Humans
  • Immunologic Factors / therapeutic use
  • Interferon alpha-2
  • Interferon beta-1b
  • Interferon-alpha / therapeutic use*
  • Interferon-beta / therapeutic use
  • Liver Function Tests
  • Male
  • Multiple Sclerosis, Relapsing-Remitting / complications
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy
  • Polyethylene Glycols / therapeutic use*
  • Recombinant Proteins
  • Viral Load

Substances

  • Antiviral Agents
  • Hepatitis B Antibodies
  • Hepatitis B Antigens
  • Immunologic Factors
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Interferon beta-1b
  • Polyethylene Glycols
  • Interferon-beta
  • peginterferon alfa-2a